Cytosystems ^Companies

Cytosystems is a pathology company that specializes in developing non-invasive cancer diagnostic and stratification technologies, with a focus on bladder cancer. Their flagship product, BladderLight™, is an integrated and automated digital pathology solution that utilizes big data systems to diagnose and monitor bladder cancer. The company has also developed two patent-pending technologies: a point of care cell collection device that optimizes analyte quality, and artificial intelligence pattern recognition software that objectively classifies urothelial cells as cancer positive or negative. These advancements in whole-cell testing provide clinicians and patients with a highly sensitive and specific non-invasive test for bladder cancer.